PT-141, or Bremelanotide – has been shown to have substantial effect on libido, creating sexual arousal in both men and women. With proper dosing PT-141 acts within 30 minutes of taking the troche and effects may be felt up to 12 hours from the time of administration and have been known to last for up to 3 days, diminishing each day. PT 141 increases sexual desire via the central nervous system and does not act upon the vascular system. PT-141 was developed from the tanning peptide Melanotan II.
- Men – Effective in treating sexual dysfunction in men – impotence / erectile dysfunction and premature ejaculation. In initial testing, Melanotan II did induce tanning but additionally caused sexual arousal and spontaneous erections as unexpected side effects in 9 our of 10 male volunteer test subjects. PT- 141 has been shown to have significant results on male test patients, with what is described as “intense” and “frequent” erections lasting between 2-6 hours.
- Women – Recent studies have shown that over 43% of the women in the United States experience little or no sexual satisfaction from orgasm and only 25% achieve orgasm with intercourse. Fortunately, there are libido treatments for women who desire greater sexual fulfillment, greater intimacy and enhanced relationships. More women reported moderate or high sexual desire following bremelanotide treatment vs. placebo. Among women who attempted sexual intercourse within 24 hours after treatment, significantly more were satisfied with their level of sexual arousal following bremelanotide, compared with placebo.